
During this event, Dr Pavel Otevřel, Medical Director of Reprofit Brno, Czechia, discussed egg donation treatment, the process, success rates, egg donors’ availability and waiting times, and when egg donation should be considered.
Egg donation is a well-established fertility treatment that has been used in clinical practice for more than 40 years. During his presentation, Dr Pavel Otevřel explained that egg donation is primarily intended for women who are unable to conceive using their own eggs due to reduced or absent ovarian function.
Dr Otevřel emphasised that the core principle of egg donation is simple: replacing eggs that no longer have sufficient reproductive potential with healthy eggs from a young donor. This approach allows many patients to achieve pregnancy even when previous IVF treatments using their own eggs have failed.
According to Dr Otevřel, the main group of patients who benefit from egg donation are women with exhausted ovaries who produce very few or no eggs. In most cases, this is related to age, as ovarian reserve and egg quality naturally decline over time.
He also described several specific patient groups for whom egg donation may be appropriate:
• younger women with premature ovarian failure
• patients whose ovarian function was damaged by chemotherapy
• women who lost ovarian tissue due to surgery, including surgery for cancer or severe endometriosis
• patients born without functioning ovaries due to genetic conditions
• women with repeated IVF failure despite adequate treatment
• patients who produce eggs but consistently create poor-quality embryos
• couples with unexplained repeated IVF failure, where changing the treatment strategy becomes necessary
In these cases, egg donation represents a shift in approach rather than a last resort. As Dr Otevřel explained, changing the cells involved in reproduction can sometimes overcome unexplained failures.
A key point of the presentation focused on egg biology and ageing. Dr Otevřel explained that a woman’s eggs are formed while she is still developing in her mother’s womb. These eggs remain dormant until puberty and are then gradually used over time.
At around 25 years of age, egg quality is at its peak. Eggs at this stage are genetically stable and have strong energy reserves, which support normal embryo development. As time passes, environmental influences and ageing processes affect egg quality, leading to increased genetic abnormalities and reduced energy supply.
Dr Otevřel explained that while implantation rates for embryos created from young eggs can be relatively high, embryos created from older eggs have a much lower chance of successful implantation. This is why replacing older eggs with younger donor eggs dramatically improves outcomes.
Importantly, he highlighted that recipient age does not significantly influence success rates in egg donation. What matters most is the age of the donor.
Some patients worry whether their bodies can accept an embryo created from a donor egg. Dr Otevřel addressed this concern by explaining immune tolerance.
Even in natural conception, an embryo is genetically different from the mother because half of its genetic material comes from the father. The female body is biologically equipped to accept this difference. Egg donation builds on this natural ability, allowing pregnancy to progress normally even when the egg is not genetically related to the recipient.
Dr Otevřel outlined the legal regulations governing egg donation treatment in the Czech Republic.
Egg donation is performed on a strictly anonymous basis. Recipients do not know the identity of the donor, and donors do not know the recipients. However, donor medical records are legally stored for 30 years, and DNA samples are retained to allow future medical clarification if needed.
Key legal points include:
• donor age limit: 18–35 years
• recipient age limit: up to the 49th birthday
• treatment limited to heterosexual couples
• donors may donate a maximum of five times
• all donation cycles are registered in a national database
In practice, Dr Otevřel explained that Reprofit accepts donors up to 32 years of age, with an average donor age of 25.5 years.
Donor recruitment is a multi-step process designed to ensure safety and quality.
The process begins with a detailed questionnaire to assess general health, lifestyle, and medical history. Candidates must be non-smokers, non-obese, and in good overall health. Many donors are university students or young mothers.
Accepted candidates then undergo:
• testing for sexually transmitted diseases
• drug screening
• psychological assessment
• genetic consultation with detailed family history analysis
• gynaecological examination, including ovarian reserve evaluation
• thyroid and hormonal assessment
Dr Otevřel explained that genetic testing is strictly regulated in the Czech Republic and controlled by state authorities. Mandatory testing includes karyotype analysis, cystic fibrosis, spinal muscular atrophy, deafness screening, and repeated infectious disease testing.
Reprofit extends testing beyond the legal minimum, with donors screened for at least 11 genetic conditions to further reduce risk.
The treatment process typically begins with an online questionnaire, followed by consultation with a coordinator and a doctor. Once egg donation is confirmed as the appropriate strategy, donor matching begins.
Finding a suitable donor usually takes six to seven weeks. Physical characteristics are considered, and recipient photos are often used to support matching.
Dr Otevřel described 2 main treatment approaches.
The first is a fresh embryo transfer cycle, which requires synchronisation of donor and recipient menstrual cycles. The donor undergoes ovarian stimulation and egg retrieval while the recipient prepares the endometrium. Fertilisation occurs after egg retrieval, and one embryo is typically transferred on day five. Remaining embryos are frozen.
The second approach separates embryo creation and transfer. Embryos are created and frozen first, without cycle synchronisation. Endometrial preparation and embryo transfer then take place at a later time. This approach can be especially suitable for women with natural ovulation.
Dr Otevřel explained that one embryo is generally recommended for transfer to reduce risks. After transfer, a pregnancy test is performed. If positive, the patient continues follow-up care with her local gynaecologist.
He stressed the importance of informing the gynaecologist about the donor egg origin and the donor’s age, as this information can be relevant for pregnancy monitoring.
Reprofit offers several treatment programmes. The standard IVF egg donation programme includes a guarantee of at least two top-quality embryos. If no suitable embryos are obtained, the patient does not pay, and a new donor cycle is initiated.
Dr Otevřel also described a baby guarantee programme, designed for patients whose infertility is primarily related to egg quality. In this programme, the goal is the birth of a healthy baby, with a money-back guarantee if this outcome is not achieved.
For couples who have already had a child through egg donation and wish for a genetically related sibling, the clinic prioritises using the same donor when legally possible. In some cases, frozen eggs or embryos from the original donor may be available.
Dr Otevřel shared clinic data from 2023 to illustrate typical outcomes:
• 800 egg donation cycles performed
• average of 11 eggs retrieved per cycle
• 9.3 mature eggs per cycle
• fertilisation rate of 80%
• average of four good-quality embryos per cycle
• pregnancy test positivity above 60%
• ongoing pregnancy rate above 50%
• take-home baby rate of 47%
He explained that, in a typical cycle, 1 embryo is transferred fresh and approximately 3 embryos are frozen.
Dr Otevřel concluded by describing a realistic timeline. Patients who decide to proceed with egg donation can often achieve a positive pregnancy test within approximately 3 months, from the initial decision to treatment completion.
The second test is done on the day of egg collection. The first test is for screening to accept the donor, and the second test is done on the day of egg collection. The result is known before the embryo transfer. There are two tests: one test three months old, and the second test three days old. This can cover the risk, and it is within the legal framework in the Czech Republic, so it is legal.
The second thing is that it was never described in the past that it is possible to transmit these mentioned diseases via oocytes. Protection is recommended, of course, but it is important mainly for sperm donors. For sperm donors, the sperm samples must be frozen for the reason you mentioned.
For egg donation, it is a different issue. We do test. Okay, we can accept that these two tests are not able to cover all the theoretical risk, but the transmission of HIV or hepatitis B/C via oocyte during the IVF process has never been described.
When we’re talking about fresh donor cycles, it means the donor must be stimulated and provide fresh oocytes. The waiting time for a good match is typically 6 to 7 weeks. If the request is easy, for instance, only a university student with no other requests, we can find a donor within 1 week.
If we’re talking about frozen oocytes, because it is also an option, we also have batches of frozen oocytes, and we can offer them. We use them mostly as a backup. It is a second choice. There is a very quick offer of a donor from day to day.
We have patients requesting this. We have established cooperation with the so-called Asian Egg Bank in California. It was not easy. It was a battle of bureaucracy because it was not easy to obtain permission to transport oocytes regularly. We did it, and we now have regular cooperation, which is approved by our controlling body.
If we have a patient with this request, they can turn to the Asian Egg Bank. We will organise the transportation of frozen oocytes from the Egg Bank to Brno, and we can start. Generally, Asian donors are very rare. They exist, but not many.
We don’t cooperate with any egg banks, where they would be available. We have to wait for volunteers. These are Czech citizens whose mother or father or both are of African origin. They live in the Czech Republic. It’s 1 or 2 ladies per year. It’s very rare.
Waiting time would be long. We basically have to refuse patients who are looking for oocytes of this origin, because it’s the heritage of socialism here. In Central Europe, there was no mixture of races. It was purely Caucasian, white people here.
Yes. There are two sheets in the genetic questionnaire during the genetic screening focused on these types of disorders: psychiatric and oncology. But of course, we depend on what the donor is open to telling us. We have no tool to control it. If the donor informs us about something in this topic in the family, the donor and family members are asked to come for a more detailed investigation. If the family is open to doing it, or the donor is not open, the candidate is refused. But if the donor signs that everything they told us is true, then they are responsible according to Czech legislation. If she lies, it’s her problem. If she covers something or doesn’t tell the truth, we have no tool to check if the family is okay. So we are dependent on what the donor fills in the questionnaire. If she mentions something, we initiate an investigation into the potential risk.
Yes. It is still acceptable that we can perform surrogacy and egg donation, but the husband or male partner must be the partner, not the donor. Double donation and surrogacy are not possible because there is no link between the biological parents and the surrogate in such a case. At least one of the parents must have a link to the baby.
However, the law is likely to change. It is possible that the combination of egg donation and surrogacy will not be allowed from 2026. We are not sure. The election is coming in the Czech Republic this autumn, so maybe it will not pass. But the request in parliament is to stop using egg donation in combination with surrogacy. We will see, next year.
Not yet. Probably because we do not have the formal pictures of donors. We only have their pictures from social media. For us, it is not the idea we talk about.
Yes. This is our daily job—not mine, but my coordinators’. If we have a patient who really insists on this topic—to have a donor as similar as possible to the recipient—we understand. It could be very important, crucial, maybe. If the couple can accept a longer waiting time, talking about 2 or 3 months, we ask our coordinators to work on it in detail, contact more donors, compare them, and we can find a similar donor. If the couple, at the beginning of the matching process, informs us that it’s really crucial, we can fulfil that request.
No. We do not ship oocytes. Never. What we can do—and it’s absolutely easy and understandable—we can ship embryos. Because the embryo is the property of the couple. But never oocytes. We are not selling oocytes. We have no permission and, second, it’s our attitude. Furthermore, we don’t want to use oocytes for shipping. We would like to treat the patient.
Of course, it is not easy to answer, but I can provide general rules. It depends. If the delay of development started immediately after fertilisation—day one, day two, day three—and embryo development was lazy or delayed, it could be the particular batch of oocytes. If everything went well until day three or four, and then the embryo arrest or declines in quality on day four or five, it could probably be the sperm. Maybe the combination of different methods of sperm selection could be offered next time, not only ZyMot but also different types of sperm selection like PICSI or MACS. Also, a non-interrupted development environment, like a time-lapse incubator, should be offered in this case to provide the best environment for embryos. I understand that it is surprising and disappointing, but it is still about probability. It is not possible to make a final recommendation or specific explanation after one failure. It could happen.
Good point. Preferably, the birth control pills don’t matter to the recipient, of course, because it is not about stimulation. It’s only about the endometrium. The recipient side could be synchronised by birth control pills with no risk. In donors, we prefer to use norethisterone rather than birth control pills for the reason mentioned in this question. Scientifically, it’s still questionable, but there is some evidence of medium weight that birth control pills could negatively affect ovarian response to stimulation. We would rather use something else than birth control pills to synchronise.
Probably, carrier testing and matching of the donor based on the carrier test is almost for sure the future. I wouldn’t refuse this point of view. If the couple is using carrier test and matching based on the carrier, we can do it. It is not expensive, nor time-consuming. We can do it. If the reason is to improve the chances, senseless—don’t do it. But if your feeling will be better when husband and donor are tested, and the match is okay, let’s do it.
We can exclude some serious diseases from your offspring. It makes sense. It is not routine because it is logistically more complicated. We have to wait for the carrier, we have to compare, and we have to open the carrier of the donor. Logistically, I have to admit it is not what we like. I think in the future, using more sophisticated PC tools, AI tools, it will be easier. I’m almost sure it is the future.
I suppose the karyotypes of the couple are normal. It must be the first step—to exclude the origin in the parents. Let’s imagine the male and female partners were tested and are okay. I would—of course it’s about inner feelings—but probably if I were in the situation, I would struggle with own oocytes undergoing PGT-A.
No impact. We standardly use down regulation. It is what would be recommended in this case—to take a down regulation shot to exclude the irregularity completely. There is no reduction in the chances. The best pregnancy rates are in patients without ovaries born. We don’t need any ovarian activity or regular ovarian activity for successful egg donation treatment. Use the down regulation protocol, and it will go easily.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
| Cookie | Duration | Description |
|---|---|---|
| _ga | 2 years | This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors. |
| _gat_UA-38575237-21 | 1 minute | No description |
| _gid | 1 day | This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form. |
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
| Cookie | Duration | Description |
|---|---|---|
| _gat_FSQM52 | 1 minute | No description |
| cf_ob_info | No description | |
| cf_use_ob | No description |